Model Informed Dosing Regimen and Phase I Results of the Anti-PD-1 Antibody Budigalimab (ABBV-181).
Clinical And Translational Science
Powderly, John J; Spira, Alexander A; Kondo, Shunsuke S; Doi, Toshihiko T; Luke, Jason J JJ; Rasco, Drew D; Gao, Bo B; Tanner, Minna M; Cassier, Philippe A PA; Gazzah, Anas A; Italiano, Antoine A; Tosi, Diego D; Afar, Daniel E DE; Parikh, Apurvasena A; Engelhardt, Benjamin B; Englert, Stefan S; Lambert, Stacie L SL; Kasichayanula, Sreeneeranj S; Mensing, Sven S; Menon, Rajeev R; Vosganian, Gregory G; Tolcher, Anthony A